Intense pulsed light (IPL) therapy using noncoherent broad-spectrum light has been reported to be effective for hair removal, and also for treating superficial pigmented lesions like ephelides and solar lentigines. We report complete regression of a pigmented melanocytic nevus, histologically confirmed, after hair removal treatment with IPL. The use of lasers and IPL is a common procedure used by dermatologists and even other professions for the treatment of cosmetically troubling skin conditions. The main advantage of such treatment is a reduction of surgical scars, thus producing a favorable cosmetic outcome, but a major limitation is that histopathologic diagnosis is not usually obtained prior to treatment. Such devices should be carefully used in patients with potentially dangerous melanocytic lesions. We also review the recent literature regarding inadequate treatment of melanocytic lesions with lasers.

Keywords:
Regression, Melanocytic lesions, Intense pulsed light, Laser, Pseudomelanoma
1.
Greve B, Raulin C: Professional errors caused by lasers and intense pulsed light technology in dermatology and aesthetic medicine: preventive strategies and case studies. Dermatol Surg 2002;28:156–161.
2.
Zipser MC, Mangana J, Oberholzer PA, French LE, Dummer R: Melanoma after laser therapy of pigmented lesions – circumstances and outcome. Eur J Dermatol 2010;20:334–338.
3.
Yamashita T, Kuwahara T, Gonzalez S, Takahashi M: Non-invasive visualization of melanin and melanocytes by reflectance-mode confocal microscopy. J Invest Dermatol 2005;124:235–240.
4.
Moreno-Arias GA, Ferrando J: Intense pulsed light for melanocytic lesions. Dermatol Surg 2001;27:397–400.
5.
Yamashita T, Negishi K, Hariya T, et al: Intense pulsed light therapy for superficial pigmented lesions evaluated by reflectance-mode confocal microscopy and optical coherence tomography. J Invest Dermatol 2006;126:2281–2286.
6.
Kawada A, Shiraishi H, Asai M, et al: Clinical improvement of solar lentigines and ephelides with an intense pulsed light source. Dermatol Surg 2002;28:504–508.
7.
Lee HW, Ahn SJ, Lee MW, Choi JH, Moon KC, Koh JK: Pseudomelanoma following laser therapy. J Eur Acad Dermatol Venereol 2006;20:342–343.
8.
Trau H, Orenstein A, Schewach-Millet M, et al: Pseudomelanoma following laser therapy for congenital nevus. J Dermatol Surg Oncol 1986;12:984–986.
9.
Hwang K, Lee WJ, Lee SI: Pseudomelanoma after laser therapy. Ann Plast Surg 2002;48:562–564.
10.
Dummer R, Kempf W, Burg G: Pseudo-melanoma after laser therapy. Dermatology 1998;197:71–73.
11.
Giacomel J, Zalaudek I, Mordente I, Nicolino R, Argenziano G: Never perform laser treatment of skin tumors with clinical ‘EFG’ criteria. J Dtsch Dermatol Ges 2008;6:386–388.
12.
Dummer R: About moles, melanomas, and lasers: the dermatologist’s schizophrenic attitude toward pigmented lesions. Arch Dermatol 2003;139:1405–1406.
13.
Gottschaller C, Hohenleutner U, Landthaler M: Metastasis of a malignant melanoma 2 years after carbon dioxide laser treatment of a pigmented lesion: case report and review of the literature. Acta Derm Venereol 2006;86:44–47.
14.
Woodrow SL, Burrows NP: Malignant melanoma occurring at the periphery of a giant congenital naevus previously treated with laser therapy. Br J Dermatol 2003;149:886–888.
15.
Grob M, Senti G, Dummer R: Delay of the diagnosis of an amelanotic melanoma due to CO2-laser treatment – case report and discussion. Schweiz Rundsch Med Prax 1999;88:1491–1494.
16.
Arndt KA: New pigmented macule appearing 4 years after argon laser treatment of lentigo maligna. J Am Acad Dermatol 1986;14:1092.
17.
Böer A, Wolter M, Kaufmann R: Pseudomelanoma following laser treatment of laser-treated melanoma? J Dtsch Dermatol Ges 2003;1:47–50.
18.
Kutzner H: Under the microscope: laser, Shave, IGEL and their outcome. Dtsch Dermatol 2001;8:248–253.
19.
Niiyama N, Niiyama S, Takasu H, et al: Progression of lentigo maligna into lentigo maligna melanoma following laser treatment. Eur J Dermatol 2007;17:252–253.
20.
Hilker O, Mainusch O: Lentigo maligna melanoma after laser treatment. Journal of the Helios Centre of Dermatology Wuppertal 2004;3:1–2.
21.
Lee PK, Rosenberg CN, Tsao H, et al: Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol 1998;38:314–317.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.